Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 86.00 GBp
Change Today +2.13 / 2.53%
Volume 0.0
PVG On Other Exchanges
Symbol
Exchange
London
Munich
OTC US
As of 11:35 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Seppo Yla-Herttuala M.D., Ph.D., FESC

AgeTotal Calculated CompensationThis person is connected to 29 board members in 1 different organizations across 2 different industries.

See Board Relationships
59--

Background*

Prof. Seppo Yla-Herttuala M.D., Ph.D. is Professor of Molecular Medicine for A.I. Virtanen Institute for Molecular Sciences and Department of Medicine, University of Kuopio, Kuopio, Finland. Dr. Yla-Herttuala is an Internationally Recognized Leader in cardiovascular gene therapy. His team was among the first to use adenovirus-mediated gene transfer in human arteries and since then, he has conducted several clinical trials in cardiovascular gene therapy. His group is ...

Read Full Background

Corporate Headquarters*

New Bond House
Bristol, Greater London BS2 9AG

United Kingdom

Phone: --
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PVG:LN 86.00 GBp +2.13

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Parker H. Petit Chairman and Chief Executive Officer
MiMedx Group, Inc.
$914.9K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PREMIER VETERINARY GROUP PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.